reglab/housing_qa huggingface dataset:
CA Health & Safety Code § 109315 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109315.

109315.  The board shall issue an order refusing to permit the application to become effective, if, after due notice to the applicant and opportunity for a hearing, the board finds any of the following:(a)  The investigations, reports that are required to be submitted to the board pursuant to subdivision (2) of Section 109300 do not include adequate tests by all methods reasonably applicable to show whether or not a drug, medicine, compound, or device is safe for use in the diagnosis, treatment, alleviation, or cure of cancer. (b)  The results of tests specified in subdivision (a) show that a drug, medicine, compound or device is unsafe for use under the conditions specified in subdivision (a) or do not show that the drug, medicine, compound, or device is safe for use under the conditions. (c)  The methods used in, and the facilities and controls used for, the manufacture, processing, and packing of a drug, medicine, compound, or device are inadequate to preserve its identity, strength, quality, and purity and with respect to a device are inadequate to preserve its safety or effectiveness. (d)  Upon the basis of the information submitted to it as part of the application, or upon the basis of any other information before it with respect to a drug, medicine, compound, or device, it has insufficient evidence to determine whether the drug, medicine, compound, or device is safe for use under the conditions specified in subdivision (a). (e)  Evaluated on the basis of the information submitted to it as part of the application and any other information before it with respect to the drug, medicine, compound, or device, there is a reasonable doubt that the drug, medicine, compound, or device will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling or advertising thereof. (f)  The application contains any untrue statement of a material fact. (Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109325 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109325.

109325.  This article and Article 1 (commencing with Section 109250) shall not apply to the use of any drug, medicine, compound, or device intended solely for legitimate and bona fide investigational purposes by experts qualified by scientific training and experience to investigate the safety and therapeutic value thereof unless the department shall find that the drug, medicine, compound, or device is being used in diagnosis or treatment for compensation and profit. In order to qualify for an exemption under this section there shall be on file with the federal Department of Health, Education, and Welfare a current and unrevoked investigational new drug application issued pursuant to subdivision (i) of Section 505 of the federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 355(i)), or the following conditions shall be complied with:(a)  The label of the drug, medicine, compound, or device shall bear the statement “Caution: New drug (or medicine or compound or device). Use in the diagnosis, treatment, alleviation, or cure of cancer limited by law to investigational use.” (b)  The drug, medicine, compound, or device has had adequate testing on appropriate experimental animals to demonstrate a lack of toxicity and hazard sufficient to permit its use in or on human beings and to establish with clarity the margins of safety ordinarily recognized by experts qualified by scientific training and experience to investigate the safety and effectiveness of the drugs, substances, or devices. (c)  The drug, medicine, compound, or device is to be used solely for investigational use by, or under the direction of, an expert qualified by scientific training and experience to investigate the safety and effectiveness of the drug, medicine, compound, or device. (d)  A written statement signed by the expert has been filed with the board. The statement shall show what facilities the expert will use for the investigation to be conducted by him or her, and that the drug, medicine, compound, or device will be used solely by him or her or under his or her direction for the investigation. The statement shall contain information identifying any assistant or agent of the expert who uses the drug, medicine, compound, or device under the direction of the expert. (e)  Complete records of the investigation shall be kept by the expert and all records shall be made available by the expert for inspection upon the request of any agent of the board at any reasonable hour as long as the expert desires exemption. (f)  The expert shall inform any persons who participate in the investigation as patients, that the drug, medicine, compound, or device is being used for investigational purposes and shall obtain the consent of the persons or their representatives. (Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109330 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109330.

109330.  Section 109300 does not apply to any device used within the scope of his or her license privileges by a physician and surgeon or dentist licensed as such in this state.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109335 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109335.

109335.  The failure of any individual, person, firm, association, or other entity representing himself, or itself, as engaged in the diagnosis, treatment, alleviation, or cure of cancer to comply with any of the regulations adopted under this article and Article 1 (commencing with Section 109250) is a misdemeanor. A third, and subsequent violations, of this section is a felony, punishable by imprisonment pursuant to subdivision (h) of Section 1170 of the Penal Code.This article and Article 1 (commencing with Section 109250) shall not apply to any person who depends exclusively upon prayer for healing in accordance with the teachings of a bona fide religious sect, denomination, or organization, nor practitioner thereof.(Amended by Stats. 2011, Ch. 15, Sec. 199. (AB 109) Effective April 4, 2011. Operative October 1, 2011, by Sec. 636 of Ch. 15, as amended by Stats. 2011, Ch. 39, Sec. 68.)
CA Health & Safety Code § 109340 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109340.

109340.  The investigation or testing of any product shall not be deemed to imply or indicate any endorsement of the qualifications or value of any product. No person shall make any representation that investigation or testing hereunder constitutes any approval or endorsement of his or her, or its, activities by the Cancer Advisory Council or the department. The investigation or testing of any product shall not be deemed to imply or indicate that the product is useless or harmful and during testing no person shall make any representation, except to the department or Cancer Advisory Council, that the product under test is discredited or that it has been found useless or harmful.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109345 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109345.

109345.  Following an investigation or testing of the content or composition of any drug, medicine, compound, or device used by any individual, person, firm, association, or other entity in the diagnosis, treatment, alleviation, or cure of cancer, and after hearing as provided in Section 109270, the department, upon recommendation of the Cancer Advisory Council, may direct that any individual, person, firm, association, or other entity shall cease and desist any further prescribing, recommending, or use of any drug, medicine, compound, or device, or any substantially similar drug, medicine, compound, or device, in the diagnosis or treatment of cancer.In the investigation or testing required by this article and Article 1 (commencing with Section 109250) to determine the value or lack thereof of any drug, medicine, compound or device in the diagnosis, treatment, or cure of cancer, the department shall, as it deems necessary or advisable, utilize the facilities and findings of its own laboratories or other appropriate laboratories, clinics, hospitals, and nonprofit cancer research institutes recognized by the National Cancer Institute, within this State or the facilities and findings of the Federal Government, including the National Cancer Institute. Upon a recommendation by the Cancer Advisory Council, the department shall arrange, by contract, for investigation by and submission to it of findings, conclusions, or opinions of trained scientists in the appropriate departments of universities, medical schools, clinics, hospitals, and nonprofit cancer research institutes recognized by the National Cancer Institute, and the submission to it of findings, conclusions, or opinions of other qualified scientists. Prior to the issuance of a cease and desist order under this section, the Cancer Advisory Council, by the affirmative vote of at least 11 of its members, at least one of whom shall not be a physician and surgeon, shall make a written finding of fact based on the investigation that the drug, medicine, compound, or device so investigated has been found to be either definitely harmful or of no value in the diagnosis, treatment, alleviation, or cure of cancer and the department must be satisfied beyond a reasonable doubt that the written findings of the fact are true.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109350 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109350.

109350.  The department may direct that any individual, person, firm, association, or other entity shall cease and desist any further prescribing, recommending, or use of any drug, medicine, compound, or device for which no application has been approved under this article and Article 1 (commencing with Section 109250) unless its use is exempt under Section 109325 or 109330.(Amended by Stats. 2006, Ch. 538, Sec. 423. Effective January 1, 2007.)
CA Health & Safety Code § 109355 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109355.

109355.  (a)  Any violation of this article and Article 1 (commencing with Section 109250), of the regulations adopted thereunder or of a cease and desist order issued by the department under Section 109345 or 109350 may be enjoined by the superior court in any county, on application of the department. (b)  Proceedings under this section shall be governed by Chapter 3 (commencing with Section 525) of Title 7 of Part 2 of the Code of Civil Procedure. (Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109360 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109360.

109360.  Any person against whom an injunction or cease and desist order has been issued, under this article and Article 1 (commencing with Section 109250), may not undertake to use in the diagnosis, treatment, alleviation, or cure of cancer any new, experimental, untested, or secret drug, medicine, compound, or device for which there is no approved application on file or that does not qualify for an exemption, without first submitting an application to the department.(Amended by Stats. 2006, Ch. 538, Sec. 424. Effective January 1, 2007.)
CA Health & Safety Code § 109365 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109365.

109365.  It is unlawful for any person, with the intent to defraud, to falsely represent and provide for compensation a device, substance, method or treatment as effective to diagnose, arrest, prevent, or cure cancer. Nothing in this section shall abridge the existent rights of the press.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109370 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109370.

109370.  Except as provided in Section 109335, a violation of this article and Article 1 (commencing with Section 109250) is punishable by imprisonment in the county jail for a period not exceeding one year, or in the state prison, or by a fine not exceeding ten thousand dollars ($10,000), or by both the imprisonment and fine.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109375 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109375.

109375.  The director shall investigate possible violations of this article and Article 1 (commencing with Section 109250) and report violations to the appropriate enforcement authority.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109380 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109380.

109380.  County health officers, district attorneys and the Attorney General shall cooperate with the director in the enforcement of this article and Article 1 (commencing with Section 109250).(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109385 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109385.

109385.  The department, upon recommendation of the Cancer Advisory Council, may from time to time publish reports based on its investigation or testing of any drug, medicine, compound, or device prescribed, recommended, or used by any individual, person, firm, association, or other entity, and when, in the opinion of a majority of the members of the Cancer Advisory Council, the use of any drug, medicine, compound, or device in the diagnosis, treatment or cure of cancer constitutes an imminent danger to health or a gross deception of the public, the department may take appropriate steps to publicize the same.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109390 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109390.

109390.  All hearings authorized by this article and Article 1 (commencing with Section 109250) shall be conducted in accordance with Chapter 5 (commencing with Section 11500) of Part 1, Division 3, Title 2 of the Government Code.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109395 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 2 - Prohibitions and Enforcement|Section 109395.

109395.  No provision of this article and Article 1 (commencing with Section 109250) shall preclude reconsideration of an application for use of any drug, medicine, compound or device for the diagnosis, treatment, alleviation or cure of cancer if new evidence or matter is presented to the department and the reconsideration is predicated upon compliance with the applicable sections of the law, and presentation of data developed subsequent to the applicable ruling of the board.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109500 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 5 - Labeling, Sale, and Use of DMSO|Section 109500.

109500.  As used in this article, “DMSO” means dimethyl sulfoxide.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109505 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 4 - Treatment of Cancer and Other Serious Diseases|ARTICLE 5 - Labeling, Sale, and Use of DMSO|Section 109505.

109505.  DMSO sold in California other than by prescription shall be labeled by the manufacturer, distributor, or seller to contain a description of all of the contents in the solution, statement of purity, the percent of DMSO in the solution, and the manufacturer’s name and address.The label shall contain (a) the name and address of the distributor of the DMSO, if any, (b) the name and address of the manufacturer of the finished DMSO, and (c) the manufacturer’s lot or control number. Finished DMSO means DMSO that requires no further manufacture prior to retail sale other than packaging or labeling. Whenever DMSO is sold or otherwise supplied, other than by prescription, the seller or supplier shall give additional printed material to the person receiving the DMSO that provides adequate warning against use that may be dangerous to the health of the user, and information that prescriptive DMSO is available from a physician.The label of DMSO sold pursuant to this section shall contain the following statement: “It is unlawful to represent in any way that this product is useful or safe to use for medicinal purposes.” The label shall include appropriate precautionary measures for proper handling and first aid treatment and a warning statement to keep the product out of reach of children.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109525 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 5 - Imitation Controlled Substances|ARTICLE 1 - Provisions and Definitions|Section 109525.

109525.  This chapter shall be known as the “California Imitation Controlled Substances Act.”(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109530 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 5 - Imitation Controlled Substances|ARTICLE 1 - Provisions and Definitions|Section 109530.

109530.  Unless the context otherwise requires, the definitions in this article govern the construction of this chapter.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109535 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 5 - Imitation Controlled Substances|ARTICLE 1 - Provisions and Definitions|Section 109535.

109535.  “Controlled substance” means a substance as defined in Section 11007.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109540 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 5 - Imitation Controlled Substances|ARTICLE 1 - Provisions and Definitions|Section 109540.

109540.  “Distribute” means the actual, constructive, or attempted transfer, delivery, or dispensing to another of an imitation controlled substance.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109545 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 5 - Imitation Controlled Substances|ARTICLE 1 - Provisions and Definitions|Section 109545.

109545.  “Manufacture” means the production, preparation, compounding, processing, encapsulating, packaging or repackaging, labeling or relabeling, of an imitation controlled substance.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109550 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 5 - Imitation Controlled Substances|ARTICLE 1 - Provisions and Definitions|Section 109550.

109550.  “Imitation controlled substance” means (a) a product specifically designed or manufactured to resemble the physical appearance of a controlled substance, that a reasonable person of ordinary knowledge would not be able to distinguish the imitation from the controlled substance by outward appearances, or (b) a product, not a controlled substance, that, by representations made and by dosage unit appearance, including color, shape, size, or markings, would lead a reasonable person to believe that, if ingested, the product would have a stimulant or depressant effect similar to or the same as that of one or more of the controlled substances included in Schedules I through V, inclusive, of the Uniform Controlled Substances Act, pursuant to Chapter 2 (commencing with Section 11053) of Division 10.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)
CA Health & Safety Code § 109555 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 104 - ENVIRONMENTAL HEALTH|PART 4 - DRUGS, DEVICES, AND COSMETICS|CHAPTER 5 - Imitation Controlled Substances|ARTICLE 1 - Provisions and Definitions|Section 109555.

109555.  The provisions of this chapter are cumulative, and shall not be construed as restricting any remedy, provisional or otherwise, provided by law for the benefit of any party.(Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)